ADC THERAPEUTICS SA (ADCT) Stock Analyst Ratings
NYSE:ADCT - New York Stock Exchange, Inc. - CH0499880968 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to ADCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.36. This target is 484.9% above the current price.
ADCT was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ADCT.
In the previous month the buy percentage consensus was at a similar level.
ADCT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-31 | Guggenheim | Maintains | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-24 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-01-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Stephens & Co. | Initiate | Overweight |
| 2024-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-30 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-05 | Guggenheim | Reiterate | Buy |
| 2024-03-28 | Guggenheim | Initiate | Buy |
| 2024-03-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-09 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-11-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-10 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-08-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-10 | RBC Capital | Maintains | Outperform |